Methodological issues in the economic analysis of cancer treatments
- 1 November 2006
- journal article
- review article
- Published by Elsevier in European Journal of Cancer
- Vol. 42 (17) , 2867-2875
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Hormonal therapies for early breast cancer: systematic review and economic evaluationHealth Technology Assessment, 2007
- Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancerHealth Technology Assessment, 2007
- FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR StudyJournal of Clinical Oncology, 2004
- The role of modelling in prioritising and planning clinical trialsHealth Technology Assessment, 2003
- A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancerHealth Technology Assessment, 2001
- Modelling in Health Economic EvaluationPharmacoEconomics, 2000
- A nice challenge for health economicsHealth Economics, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Economics notes: Opportunity costBMJ, 1999
- Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final ReportAnnals of Internal Medicine, 1995